ABOUT 15th_ELSF
> ATTENDEES​
> INVESTORS​
> SHOWCASES
> SPONSORS
> SUPPORTERS​

Sachs Associates would like to say we enjoyed hosting a virtual conference and thank those who participated in our Sachs Spring Life Sciences Week. A special thank you goes to the excellent line up of sponsors, chairpersons, panelists and presenters who made such a broad and interesting programme possible.

The virtual conference is proving successful in supporting our community with 521 people from 33 countries registered and a high number of online meetings completed during the Sachs Spring Life Sciences Week.

SPOTLIGHT SHOWCASES INCLUDED:

Showcases Included:

Confirmed Chairs & Speakers Included:

• Alexandre Bastos, Head of Front End Innovation, Givaudan
• Andrea Carfi, Chief Scientific Officer, Infectious Disease, Moderna, Inc.
• Andreas Hohn, Director of Transaction Excellence, Roche Partnering, F. Hoffmann-La Roche Ltd.
• Andrew Allen, Co-Founder, President & CEO, Gritstone Bio, Inc.
• Aram Mangasarian, CEO, NOXXON Pharma NV
• Bibhash Mukhopadhyay, Founder & Managing Partner, Sound Bioventures Management AB
• Christina Hertel, Senior Program Manager – Gold Track, EIT Health e.V.
• Corinne Venot, Executive Director, Business Development, BeiGene Ltd.
• Daniel Teper, Co-Founder, Chairman & CEO, Cytovia Therapeutics Inc.
• Diana Saraceni, Co-Founder & General Partner, Panakès Partners SGR SpA
• Didier Toubia, Co-Founder, CEO of Aleph Farms
• Duncan Young, Senior Director, Search & Evaluation, Oncology R&D, AstraZeneca
• Emmanuelle Coutanceau, Partner, Novo Seeds, Novo Holdings A/S
• Eric Halioua, President & CEO, PDC*line Pharma SA
• Esteban Pombo-Villar, CTO, TargImmune Therapeutics AG
• Fintan Walton, Founder & CEO, PharmaVentures Ltd.
• Fiona Choppe Magal, Partner, Cukierman & Co. Investment House, FoodTech & Agritech
• Florian Schödel, Owner, Philimmune, LLC
• Gabriel Cavazos, Senior Managing Director, Investment Banking, SVB Leerink
• George Frodsham, Founder & CEO, MediSieve
• Gil Bar-Nahum, Managing Director, EMEA Head of Biotechnology, Jefferies International Ltd.
• Gregor Macdonald, VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S
• Hany Awadalla, Managing Director & Head of Investment Banking, LifeSci Capital LLC
• Hubert Birner, Managing Partner, TVM Life Science Management GmbH
• Holger Kissel, Vice President Business Alliances, BioNTech SE
• Ilan Sobel, CEO, BioHarvest Sciences Inc.
• Jan de Kerpel, Managing Director, Head of Life Sciences & Healthcare Kempen & Co
• Juan Carlos Jaramillo, Chief Medical Officer, Valneva SE
• Kaare Engkilde, CEO, Amniotics AB
• Katya Smirnyagina, Senior Partner for Life Sciences, Oxford Sciences Innovation
• Kay Penicud, Director of Innovation and Business, UK Dementia Research Institute
• Khatereh Ahmadi, Head of Search & Evaluation Business Development, Europe & Middle East, MSD
• Kylor Hua, Executive Director, Torreya
• Lynn Durham, Founder & CEO, STALICLA SA
• Marietta Wu, Managing Director, Quan Capital
• Matthias Müllenbeck, SVP, Head Global BD & Alliance Management, Merck KGaA
• Max Herrmann, Head of UK Healthcare Equity Research, Stifel Financial Corp.
• Meredith Fisher, Partner, Mass General Brigham Ventures
• Michael Altorfer, CEO, Swiss Biotech Association
• Michael Cozart, Managing Partner, LifeSci Consulting
• Michael Friedrich, CEO, Distalmotion SA
• Michael Margolis, Senior Managing Director, Co-Head, Healthcare Investment Banking, Oppenheimer & Co. Inc
• Michael Rice, VP, Head of Advanced Therapeutics & Rare Diseases, Cello Health BioConsulting
• Miguel Forte, CEO, Bone Therapeutics SA
• Mike Romanos, Co-Founder & CEO, Microbiotica Ltd.
• Mythili Koneru, CMO, Marker Therapeutics, Inc.
• Nanna Lüneborg, General Partner, Forbion
• Narender Mantena, CEO, Biological E Limited
• Nathalie ter Wengel, European Lead, Worldwide Business Development, Pfizer, Inc.
• Nicholas Franco, EVP & Chief Business Development Officer, Allschwil Site Head, Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson
• Nicholas Moore, Managing Director, Healthcare Investment Banking, Stifel Nicolaus Europe Limited
• Niels Emmerich, VP, Global Head Search & Evaluation, AbbVie, Inc.
• Paul Hermant, Partner, Bird & Bird LLP
• Peter Llewellyn-Davies, CEO/CFO, invIOs GmbH
• Rainer Strohmenger, Managing Partner, Wellington Partners Life Sciences (WPLS)
• Reagan Jarvis, CEO, Anocca AB
• Renee Aguiar-Lucander, CEO, Calliditas Therapeutics AB
• Robert de Jonge, VP Head of Corporate Development, Mestag Therapeutics Ltd.
• Ros Deegan, CEO, OMass Therapeutics
• Ryan Richardson, Chief Strategy Officer, BioNTech SE
• Sam Fazeli, Head of Research, Senior Pharmaceuticals Analyst, Bloomberg Intelligence
• Sascha Berger, General Partner, TVM Life Science Management GmbH
• Sandra Ferri, Head of Life Sciences Investments, European Investment Fund
• Sarah Holland, CBO, VectivBio AG
• Shafique Virani, Chief Corporate Development Officer, Recursion, Inc.
• Søren Møller, Managing Partner, Novo Holdings A/S
• Speaker TBA, BeiGene Ltd.
• Stephanie Léouzon, Partner & Head of Europe, Torreya
• Stephen Myatt, CEO, Macomics Ltd.
• Steve Rees, Vice President of Discovery Biology, AstraZeneca
• Theodora Harold, CEO, Crescendo Biologics Ltd.
• Thibaut Roulon, Senior Investment Director, Bpifrance
• Thijs Cohen Tervaert, Junior Partner, INKEF Capital BV
• Thomas Roth, CEO, Inzipio GmbH
• Thomas Shrader, Managing Director & Healthcare Analyst, BTIG, LLC
• Tim Dyer, Co-Founder, Board Director & CEO, Addex Therapeutics Ltd.
• Tim Haines, Chairman & Managing Partner, Abingworth LLP
• Tim Luker, VP Venture Science, Corp BD, Eli Lilly and Company
• Volker Germaschewski, SVP R&D, eTheRNA immunotherapies NV
• Yonatan Golan, CEO, Brevel Ltd.
  

Silver Sponsors:

---

Bronze Sponsor:

---

Contributing Sponsors:

---

Supporters:

---

Participating Pharmas:

---

Investors & Analysts attending:

3B Future Health Ventures
6 Dimensions Capital
Abingworth LLP
Additio Investment Group
Aescuvest International
Aglaia Oncology Funds
Allele Capital Partners
Alpha Blue Ocean Ltd.
ALSA Ventures
Amadeus Capital Partners
Apeiron Investments
Apollo Health Ventures
Aqua Partners LLC
ARCH Venture Partners
Arix Bioscience plc
Asabys Partners
Ascend Capital Partners
Asklepios Advisors
ATGN Consulting
ATP (Apple Tree Partners)
AurorA Science Srl
AVANTECA Partners AG
BaseLaunch
Bergmann zur Hausen & Cie. GmbH
BERNINA BioInvest Ltd.
Big Pi Ventures SCSp
BIMA Capital, LLC
Bio Medi Gene Ventures
BioMedPartners AG
Bionova Capital SCR SA
BioPharma Advisory
Bioqube Ventures
BIOSTART Consulting GmbH
BioValley Basel & Suterscience, LLC
BioVeda China Fund (BVCF)
Bootstrap Europe SCSP
Bpifrance
Bradley Woods & Co. Ltd
Brandon Capital Partners
Breslin AG
Brightlands Venture Partners


To View All - Click Here